TP53 and non-small cell lung carcinoma: Increasing evidences advocate the concept that some molecular markers including epidermal growth factor receptor (EGFR) [10], p53 [11] and excision repair cross complementing gene 1 (ERCC1) [12] are associated with chemotherapy resistance in NSCLC.